[Hepatitis B vaccination among school children]. 1995

L Egea, and J R Villalbí, and M Nebot

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D006509 Hepatitis B INFLAMMATION of the LIVER in humans caused by a member of the ORTHOHEPADNAVIRUS genus, HEPATITIS B VIRUS. It is primarily transmitted by parenteral exposure, such as transfusion of contaminated blood or blood products, but can also be transmitted via sexual or intimate personal contact. Hepatitis B Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D013030 Spain Country located between France on the northeast and Portugal on the west and bordered by the Atlantic Ocean and the Mediterranean Sea. The capital is Madrid. Balearic Islands,Canary Islands
D014611 Vaccination Administration of vaccines to stimulate the host's immune response. This includes any preparation intended for active immunological prophylaxis. Immunization, Active,Active Immunization,Active Immunizations,Immunizations, Active,Vaccinations
D017325 Hepatitis B Vaccines Vaccines or candidate vaccines containing inactivated hepatitis B or some of its component antigens and designed to prevent hepatitis B. Some vaccines may be recombinantly produced. Hepatitis B Vaccine,Vaccine, Hepatitis B,Vaccines, Hepatitis B

Related Publications

L Egea, and J R Villalbí, and M Nebot
January 2000, Asian American and Pacific Islander journal of health,
L Egea, and J R Villalbí, and M Nebot
November 2001, The Pediatric infectious disease journal,
L Egea, and J R Villalbí, and M Nebot
December 1999, The Journal of the Louisiana State Medical Society : official organ of the Louisiana State Medical Society,
L Egea, and J R Villalbí, and M Nebot
December 2004, Communicable disease and public health,
L Egea, and J R Villalbí, and M Nebot
September 1996, Pediatrics,
L Egea, and J R Villalbí, and M Nebot
September 1997, Deutsche medizinische Wochenschrift (1946),
L Egea, and J R Villalbí, and M Nebot
January 2008, Indian journal of community medicine : official publication of Indian Association of Preventive & Social Medicine,
L Egea, and J R Villalbí, and M Nebot
June 2003, Revista de saude publica,
L Egea, and J R Villalbí, and M Nebot
September 2012, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Copied contents to your clipboard!